Clinical Report: Induced Pluripotent Stem Cells for Modeling Monogenic Disorders
Overview
Induced pluripotent stem cells (iPSCs) derived from patients provide a novel platform for studying specific monogenic disorders affecting beta cell function, such as Maturity-onset diabetes of the young (MODY) and congenital hyperinsulinism, which are critical for understanding diabetes pathophysiology and developing targeted therapies.
Background
Monogenic disorders of beta cell dysfunction are crucial for research due to their implications for diabetes treatment and understanding disease mechanisms. These rare conditions, while individually uncommon, collectively provide insights into the molecular regulation of beta cell identity and function, which is essential for developing targeted therapies.
Data Highlights
No numerical data presented in the article.
Key Findings
iPSCs can be derived from patients with monogenic beta cell disorders, enabling personalized disease modeling. Studies using iPSC-derived SC-islets have demonstrated defects in insulin secretion and beta cell maturation in MODY subtypes. Congenital hyperinsulinism has been modeled using iPSC-derived SC-islets, revealing excess insulin secretion and increased beta cell proliferation. Genome editing in iPSC models allows for the generation of isogenic controls to study genotype-phenotype relationships. Challenges remain in achieving complete functional maturation of SC-islets, necessitating ongoing refinement of differentiation protocols.
Clinical Implications
The use of iPSC-derived models can enhance the understanding of monogenic beta cell disorders and inform genotype-guided treatment strategies. Clinicians should consider genetic testing for patients with atypical diabetes presentations to identify potential monogenic causes and tailor therapies accordingly.
Conclusion
iPSC technology represents a transformative approach to studying monogenic disorders of beta cell function, with significant implications for precision medicine in diabetes care. Continued research in this area may lead to improved therapeutic options for affected patients, emphasizing the need for further exploration of these models.
